clinicaltrialsarena1h
Innate Pharma doses first patient in Nectin-4 ADC trial
The Phase I ADC trial will evaluate the safety and efficacy of the company’s drug which targets tumours whilst leaving normal ...
clinicaltrialsarena3h
Novo Nordisk reports topline data from Phase Ib/IIa trial of weight loss therapy
Novo Nordisk has reported topline outcomes from a Phase Ib/IIa trial of amycretin designed for treating obese or overweight ...
clinicaltrialsarena2d
MSD and Eisai’s LEAP gastroesophageal cancer trial sees mixed success
MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free survival, but ...
clinicaltrialsarena2d
Traws Pharma completes Phase I trials of H5N1 bird flu treatment drug
Traws Pharma has completed the Phase I clinical trials of tivoxavir marboxil, a single-dose drug for treating or preventing ...
clinicaltrialsarena3d
Rakuten doses first patients in multi-continental Phase III HNSCC trial
The trial builds off the previous Phase Ia/II trial that saw an estimated survival rate of 52.4% at 24 months in patients ...
clinicaltrialsarena3d
High consumption of red meat causes dementia
GlobalData epidemiologists forecast a rise in dementia cases in the US from 2.97 million in 2024 to 4.06 million by 2033.
clinicaltrialsarena3d
Medidata extends partnership with Tigermed to enhance clinical trial processes
Medidata has announced the extension of its partnership of 13 years with Tigermed to enhance clinical trial processes.
clinicaltrialsarena3d
Genprex doses first subject in expansion part of lung cancer gene therapy trial
The combination regimen will be assessed as a maintenance therapy to treat extensive stage small cell lung cancer patients. Credit: Jo Panuwat D/Shutterstock. Genprex has dosed the first subject in ...